Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:09:53 +0200Wed, 05 Jun 2024 14:00:00 +0200Alprolix : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4142-steps-after_en.pdfAlprolix : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4142-steps-after_en.pdfWed, 05 Jun 2024 14:00:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 9, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/alprolixHuman medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 9, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/alprolixWed, 05 Jun 2024 13:53:00 +0200Human medicine